You just read:

Capricor Therapeutics Announces Plans to Expand Clinical Development Program in Duchenne Muscular Dystrophy to Evaluate Peripheral and Respiratory Muscle Function

News provided by

Capricor Therapeutics, Inc.

Nov 10, 2016, 16:05 ET